Researchers have developed a biodegradable ultrasound contrast agent that enables non-invasive and dynamic tracking of intestinal motility. Addressing limitations of existing imaging modalities in gastroenterology, this innovation promises enhanced safety and clarity in monitoring gastrointestinal functions, potentially facilitating better diagnostic and treatment decisions.